Johnson & Johnson pledges not to enforce bedaquiline patents, opening pathway for generic drug manufacturing Posted on Oct 27, 2023 Following Friday’s precedent-setting announcement that in low- and middle-income countries Johnson & Johnson will not enforce patents on bedaquiline, a key drug in the fight against multidrug-resistant tuberculosis (MDR-TB), Partners Read more…
Enrollment signals step forward in global effort to end tuberculosis Posted on Oct 25, 2021 In Lima, Peru, Gaby Merlin Contreras, a field technician with Socios En Salud, administers treatment to a patient living with XDR-TB as part of the endTB project in March 2016. (Photo by William Castro Rodríguez / Read more…
PIH’s care for Hassan, an MDR-TB patient, creates a national impact Posted on July 23, 2021 From the time he was admitted to Lakka Government Hospital, Sierra Leone’s only dedicated tuberculosis facility, staff knew that 18-year-old Hassan* was special. “He’s a very brilliant boy,” said Armah Quist, program officer at the Partners Read more…
Socios En Salud celebrates quarter century of lifesaving care, systemic change Posted on Jul 6, 2021 A quarter of a century ago, in the hillside communities of Carabayllo, Partners In Health dared to pursue a simple yet radical idea: no patient should die because a disease was considered “too expensive” Read more…
PIH doctor reflects on challenges, setbacks, and silver linings for health systems Posted on April 5, 2021 The COVID-19 pandemic has severely disrupted care and services for people living with tuberculosis—until recently the world’s deadliest infectious disease—draining or diverting resources and potentially costing hundreds of thousands of lives that could have Read more…
Fighting two of the world’s deadliest diseases, PIH Lesotho’s Maseru facility is boosting vital infrastructure and conducting outreach across the country Posted April 3, 2021 Partners In Health and Lesotho’s Ministry of Health marked World TB Day with two distinct actions: conducting community tuberculosis screenings in rugged Buta-Buthe District, one of the Read more…
A case of MDR-TB left Saffiatu Sesay feeling hopeless—then inspired her to care for others Posted on March 24, 2021 At the center of the campus of Lakka Government Hospital, a mango tree stands, its wide branches offering a shaded gathering spot for patients looking for conversation and camaraderie. Many Read more…
EndTB clinical trial shortens treatment period, helps dozens return to normal life Posted March 24, 2021 While pregnant with her second child, Maral Shorayeva began experiencing symptoms that felt like a cold or flu, but when she went to give birth to her daughter, doctors recognized that something was wrong. Read more…
Q&A with Dr. Carole Mitnick, PIH’s co-principal investigator of endTB project Tuberculosis is the most deadly infectious disease, killing more than 1.4 million people globally, most of them in resource-poor countries. Some forms of the disease are resistant to treatment and therefore can’t be cured using standard drugs. These multidrug Read more…
Despite Kazakhstan’s nationwide lockdown that began in March to contain COVID-19, Partners In Health clinicians have continued to examine and provide treatment—in person and online—for tuberculosis patients enrolled in a groundbreaking clinical trial. Clinicians have had to communicate regularly with police to cross checkpoints and have used their own vehicles Read more…